Tendon Tissue Engineering is a multidisciplinary field focused on developing innovative strategies to repair or replace damaged tendon tissue using a combination of cells, biomaterial scaffolds, and bioactive factors. Tendons, critical for transmitting forces between muscles and bones, often face challenges in healing due to their limited vascularity and slow cell turnover. Tendon tissue engineering aims to address these limitations by creating functional, biocompatible substitutes. The process typically involves isolating tenocytes or tendon progenitor cells, seeding them onto biodegradable scaffolds that mimic the tendon's extracellular matrix (ECM), and providing appropriate biochemical signals for cell proliferation and matrix synthesis. Various biomaterials, such as hydrogels and electrospun fibers, are employed to create scaffolds with optimal mechanical properties. Additionally, growth factors and mechanical stimulation are integrated to enhance cell differentiation and tissue maturation. Successful tendon tissue engineering endeavors to replicate the native tendon's biomechanical strength, flexibility, and functionality. This approach holds promise for treating tendon injuries, degenerative conditions, and providing alternatives to traditional tendon grafts. Researchers continually refine techniques and explore new materials to improve the efficacy and clinical applicability of tendon tissue engineering, offering potential breakthroughs in regenerative medicine for musculoskeletal disorders.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States